ProQR Therapeutics (PRQR) Current Assets (2013 - 2026)
ProQR Therapeutics (PRQR) posted Current Assets of $101.8 million for Q1 2026, down 12.63% sequentially from $116.6 million in Q4 2025, and down 29.89% YoY from $145.2 million in Q1 2025.
ProQR Therapeutics (PRQR) Current Assets (2013 - 2026) Analysis & Trends
ProQR Therapeutics has reported Current Assets for 14 years, with the latest figure at $101.8 million in Q1 2026.
- Quarterly Current Assets fell 29.89% year-over-year to $101.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $101.8 million (down 29.89% YoY) and the FY2025 annual result came in at $116.6 million, down 29.1% from the prior year.
- Current Assets retreated to $101.8 million in Q1 2026 per PRQR's latest filing, from $116.6 million in the prior quarter.
- Over five years, Current Assets peaked at $193.6 million in Q1 2022 and troughed at $101.5 million in Q3 2024.
- A 5-year average of $136.2 million and a median of $135.7 million in 2023 frame the typical range for Current Assets.
- The widest YoY moves for Current Assets: up 220132.99% in 2022, down 49.73% in 2022.
- Over 5 years, Current Assets stood at $157.6 million in 2022, then decreased by 17.4% to $130.2 million in 2023, then increased by 26.29% to $164.4 million in 2024, then retreated by 29.1% to $116.6 million in 2025, then fell by 12.63% to $101.8 million in 2026.
- According to Business Quant data, Current Assets over the past three periods registered $101.8 million, $116.6 million, and $130.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 8.07 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.03 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 7.22 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 11.83 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 1.76 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.62 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.63 Bn |
| 10 | ProQR Therapeutics | 206.80 Mn | 111.86 Mn | - | 101.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 101.83 Mn |
| Dec 31, 2025 | 116.55 Mn |
| Sep 30, 2025 | 130.15 Mn |
| Jun 30, 2025 | 140.68 Mn |
| Mar 31, 2025 | 145.25 Mn |
| Dec 31, 2024 | 164.40 Mn |
| Sep 30, 2024 | 101.49 Mn |
| Jun 30, 2024 | 109.59 Mn |
| Mar 31, 2024 | 116.41 Mn |
| Dec 31, 2023 | 130.17 Mn |
| Sep 30, 2023 | 135.73 Mn |
| Jun 30, 2023 | 142.81 Mn |
| Mar 31, 2023 | 152.00 Mn |
| Dec 31, 2022 | 157.59 Mn |
| Sep 30, 2022 | 104.97 Mn |
| Jun 30, 2022 | 171.86 Mn |
| Mar 31, 2022 | 193.57 Mn |
| Dec 31, 2021 | 219.05 Mn |
| Sep 30, 2021 | 208.80 Mn |
| Jun 30, 2021 | 172.91 Mn |